Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Anika Therapeutics Inc

Current price
24.62 USD +0.72 USD (+3.01%)
Last closed 24.21 USD
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 354 456 160 USD
Yield for 12 month -22.51 %
21.11.2021 - 28.11.2021

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and bone preserving joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief; and Hyvisc, a molecular weight injectable HA veterinary product. The company's joint preservation and restoration product family comprises 150 bone preserving joint technology products, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and orthopedic regenerative solutions, including Hyalofast and Tactoset. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including adhesion barrier, advanced wound care, ear, nose, and throat products, as well as ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts. Address: 32 Wiggins Avenue, Bedford, MA, United States, 01730

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

27.67 USD

P/E ratio

Dividend Yield

Current Year

+163 313 000 USD

Last Year

+156 236 000 USD

Current Quarter

+41 465 000 USD

Last Quarter

+44 302 000 USD

Current Year

+100 890 000 USD

Last Year

+93 576 000 USD

Current Quarter

+24 944 000 USD

Last Quarter

+28 972 000 USD

Key Figures ANIK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -27 905 000 USD
Operating Margin TTM -16.7 %
PE Ratio
Return On Assets TTM -7.81 %
PEG Ratio 3.1868
Return On Equity TTM -8.85 %
Wall Street Target Price 27.67 USD
Revenue TTM 163 312 992 USD
Book Value 18.48 USD
Revenue Per Share TTM 11.15 USD
Dividend Share
Quarterly Revenue Growth YOY 3 %
Dividend Yield
Gross Profit TTM 96 775 000 USD
Earnings Share -1.68 USD
Diluted Eps TTM -1.68 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -50.5 %
Profit Margin -15.05 %

Dividend Analytics ANIK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ANIK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ANIK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 78.7402
Enterprise Value Revenue 1.9173
Price Sales TTM 2.1704
Enterprise Value EBITDA -19.3088
Price Book MRQ 1.3104

Financials ANIK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ANIK

For 52 weeks

16.54 USD 32.33 USD
50 Day MA 22.97 USD
Shares Short Prior Month 521 734
200 Day MA 22.31 USD
Short Ratio 6.88
Shares Short 527 838
Short Percent 5.13 %

Dynamics of changes in the value of assets




402.79 USD Microsoft Corporation -0.45 (-0.11%)
Detailed analytics

ETF funds



11.59 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics



2031.07 USD Gold +9.2 (+0.46%)
Detailed analytics